Market Tracker

07/26 4:54pm ET

Array Biopharma Inc (NASDAQ:ARRY)

7.77
Delayed Data
As of Jul 26
 -0.09 / -1.15%
Today’s Change
3.10
Today|||52-Week Range
13.40
-11.60%
Year-to-Date
New Strong Sell Stocks for July 20th
Jul 20 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close7.86
Today’s open7.86
Day’s range7.73 - 7.94
Volume1,479,888
Average volume (3 months)3,581,047
Market cap$1.3B
Dividend yield--
Data as of 4:00pm ET, 07/26/2017

Growth & Valuation

Earnings growth (last year)-1,028.57%
Earnings growth (this year)-17.26%
Earnings growth (next 5 years)+16.00%
Revenue growth (last year)+165.62%
P/E ratioNM
Price/Sales3.69
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CORTCorcept Therapeutics...-0.14-1.13%
IPXLImpax Laboratories I...+0.35+1.80%
GBTGlobal Blood Therape...-0.80-2.79%
INVAInnoviva Inc+0.08+0.61%
Data as of 4:00pm ET, 07/26/2017

Financials

Next reporting dateAugust 15, 2017
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$137.9M
Annual profit (last year)-$92.8M
Net profit margin-67.33%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ron Squarer
Chief Operating Officer
Andrew R. Robbins
Corporate headquarters
Boulder, Colorado

Forecasts